Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Quanterix announces launch of new SR-Plex benchtop instrument for high sensitivity biomarker analysis

Quanterix Corporation, a company dedicated to digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it will be expanding its single molecule array, or Simoa, technology platform portfolio to include the new Quanterix SR-Plex benchtop instrument.

23 Aug 2017

Retina scans could help identify Alzheimer’s

Researchers at the Cedars-Sinai and NeuroVision Imaging LLC have made it possible to identify the pathological markers of Alzheimer’s using retinal scans. These scans are non- invasive and could be performed routinely in future to detect this dreaded form of degenerative brain disease. The paper was published online in the JCI Insight on 17th of August.

22 Aug 2017

Artificial intelligence technique recognizes signatures of dementia two years before onset

Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care.

22 Aug 2017

Noninvasive retinal imaging may detect pathological hallmarks of Alzheimer's disease

A study led by researchers at Cedars-Sinai and NeuroVision Imaging LLC provides the scientific basis for using noninvasive eye imaging to detect the pathological hallmarks of Alzheimer's.

22 Aug 2017

Researchers get closer to creating new blood test that can identify breast cancer brain metastasis

Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response to therapy in real time.

17 Aug 2017

Insilico and GSK collaborate to enhance drug discovery process

Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.

16 Aug 2017

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

14 Aug 2017

Small clinical trial shows promise for treating rare neurodegenerative disease

Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.

11 Aug 2017

Portable spectral analyzer enables smartphone to perform lab-grade medical diagnostic tests

Researchers at the University of Illinois at Urbana-Champaign have developed technology that enables a smartphone to perform lab-grade medical diagnostic tests that typically require large, expensive instruments.

10 Aug 2017

Biological bypass found safe for patients with coronary artery disease

A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease, according to a successful trial carried out in Finland.

8 Aug 2017

Newly discovered biomarker linked to rare metabolic disorders may facilitate better diagnosis

A newly discovered biomarker associated with a rare metabolic disorder may facilitate better diagnosis and identification of new drugs for clinical trials for the disease, according to researchers in the Perelman School of Medicine at the University of Pennsylvania.

7 Aug 2017

Scientists creating blood test to identify breast cancer patients at risk for brain metastasis

4 Aug 2017

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2017 Annual Meeting in Denver, Colorado. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.

2 Aug 2017

Shaping the future of oncology treatment

Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.

2 Aug 2017

Researchers streamline beta cell differentiation process to develop safer cell therapy for diabetes

More than 36 million people globally are affected by type 1 diabetes (T1D), a lifelong disorder where insulin producing cells are attacked and destroyed by the immune system resulting in deficient insulin production that requires daily blood glucose monitoring and administration of insulin.

1 Aug 2017

Inflammatory biomarkers may help diagnose chronic fatigue syndrome

Researchers have discovered inflammation biomarkers that could help scientists to research, diagnose and even treat chronic fatigue syndrome (CFS). Also referred to as myalgic encephomyelitis, CFS is a poorly-understood condition characterized by profound, long-term tiredness.

1 Aug 2017

Biomarker News and Research

Further Reading

Quanterix announces launch of new SR-Plex benchtop instrument for high sensitivity biomarker analysis

Retina scans could help identify Alzheimer’s

Artificial intelligence technique recognizes signatures of dementia two years before onset

Noninvasive retinal imaging may detect pathological hallmarks of Alzheimer's disease

Researchers get closer to creating new blood test that can identify breast cancer brain metastasis

Insilico and GSK collaborate to enhance drug discovery process

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Small clinical trial shows promise for treating rare neurodegenerative disease

Portable spectral analyzer enables smartphone to perform lab-grade medical diagnostic tests

Biological bypass found safe for patients with coronary artery disease

Newly discovered biomarker linked to rare metabolic disorders may facilitate better diagnosis

Scientists creating blood test to identify breast cancer patients at risk for brain metastasis

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

Shaping the future of oncology treatment

Researchers streamline beta cell differentiation process to develop safer cell therapy for diabetes

Inflammatory biomarkers may help diagnose chronic fatigue syndrome

Research scientist at Kessler Foundation receives $231,000 grant from American Heart Association

Newly discovered physical biomarkers could help pinpoint stage-specific prognosis of Alzheimer’s

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

Roche receives FDA clearance for new Troponin T test to detect patients with suspected heart attack

Event guide: World Clinical Biomarkers & CDx Summit Japan eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo